[go: up one dir, main page]

EP1959929A4 - Compositions et procedes pour le traitement de conditions dermatologiques - Google Patents

Compositions et procedes pour le traitement de conditions dermatologiques

Info

Publication number
EP1959929A4
EP1959929A4 EP06847657A EP06847657A EP1959929A4 EP 1959929 A4 EP1959929 A4 EP 1959929A4 EP 06847657 A EP06847657 A EP 06847657A EP 06847657 A EP06847657 A EP 06847657A EP 1959929 A4 EP1959929 A4 EP 1959929A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
dermatological conditions
treating dermatological
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06847657A
Other languages
German (de)
English (en)
Other versions
EP1959929A2 (fr
Inventor
Jie Zhang
Kevin S Warner
Sanjay Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZARS Pharma Inc
Original Assignee
ZARS Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZARS Pharma Inc filed Critical ZARS Pharma Inc
Publication of EP1959929A2 publication Critical patent/EP1959929A2/fr
Publication of EP1959929A4 publication Critical patent/EP1959929A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP06847657A 2005-12-14 2006-12-14 Compositions et procedes pour le traitement de conditions dermatologiques Withdrawn EP1959929A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US75052205P 2005-12-14 2005-12-14
US75046505P 2005-12-14 2005-12-14
US75063705P 2005-12-14 2005-12-14
US75052405P 2005-12-14 2005-12-14
PCT/US2006/047747 WO2007070643A2 (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement de conditions dermatologiques

Publications (2)

Publication Number Publication Date
EP1959929A2 EP1959929A2 (fr) 2008-08-27
EP1959929A4 true EP1959929A4 (fr) 2012-08-15

Family

ID=38163526

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06847657A Withdrawn EP1959929A4 (fr) 2005-12-14 2006-12-14 Compositions et procedes pour le traitement de conditions dermatologiques

Country Status (6)

Country Link
EP (1) EP1959929A4 (fr)
JP (1) JP2009519940A (fr)
CN (1) CN101378729B (fr)
AU (1) AU2006326388B2 (fr)
CA (1) CA2633489C (fr)
WO (1) WO2007070643A2 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
WO2010008600A1 (fr) * 2008-07-16 2010-01-21 Dermworx Incorporated Système d'apport de médicament topique
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
KR20110067145A (ko) 2008-10-03 2011-06-21 넥스메드 홀딩스 인코포레이티드 건선 치료용 안정화된 조성물
WO2010069519A1 (fr) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Compositions topiques comprenant au moins un ingrédient actif difficilement soluble dans l'eau et des biopolymères, tels que l'acide hyaluronique, présentant une valeur pka située entre 5 et 7
WO2010091274A1 (fr) * 2009-02-06 2010-08-12 Skinvisible Pharmaceuticals, Inc. Composition contenant un composant pharmaceutiquement actif cationique, ses méthodes de fabrication et d'utilisations
ES2468540T3 (es) 2009-02-13 2014-06-16 Topica Pharmaceuticals, Inc Formulación antif�ngica
BRPI1009982A2 (pt) 2009-05-01 2017-06-27 Signal Investment & Man Co composição antimicrobiana hidratante
EP2453747B1 (fr) 2009-07-13 2017-08-30 Medicis Pharmaceutical Corporation Formulations d'imiquimod à intensité de dosage plus faible et régimes posologiques courts pour traiter des verrues génitales et périanales
GB2479544A (en) * 2010-04-13 2011-10-19 Brands Worldwide Holdings I P Pty Ltd Film forming material to reduce skin irritation due to friction
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
WO2012107564A1 (fr) 2011-02-10 2012-08-16 Moberg Derma Ab Nouvelles préparations pour utilisation cutanée, transcutanée et par voie muqueuse
EP2510930A1 (fr) 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanoparticules comportant des semi-esters de poly (méthyl vinyl éther-co-maléique anhydride) et leurs utilisations
AU2012363635B2 (en) * 2012-01-03 2015-07-23 Cellceutix Corporation Carbocyclic nucleosides and their pharmaceutical use and compositions
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
CN103191408B (zh) * 2013-04-19 2014-02-12 江苏迪沃生物制品有限公司 一种治疗阴道炎的药物组合物、凝胶剂及其用途
CN103301089B (zh) * 2013-07-08 2015-01-07 广东彼迪药业有限公司 一种泛昔洛韦胶囊制剂及其制备方法
CA2924748C (fr) 2013-10-03 2019-09-03 Dow Pharmaceutical Sciences, Inc. Formules d'efinaconazole stabilise
CN103589886A (zh) * 2013-11-17 2014-02-19 湖南金马铝业有限责任公司 一种粉末冶金法生产碳化硅铝基复合材料用粘结剂
CA2931144C (fr) 2013-11-22 2020-02-04 Dow Pharmaceutical Sciences, Inc. Procedes, compositions et dispositifs anti-infectieux
CN103933545B (zh) * 2014-05-14 2015-06-17 深圳市红瑞生物科技有限公司 治疗真菌感染的药物及其制备方法
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions
FR3025718A1 (fr) * 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
EP3251695A4 (fr) 2015-01-30 2018-08-01 MEDRx Co., Ltd. Préparation aqueuse à usage externe
EP3426706A1 (fr) 2016-03-08 2019-01-16 Living Proof, Inc. Compositions cosmétiques longue durée
CN106074732A (zh) * 2016-07-21 2016-11-09 吕令中 一种治疗牛皮癣的药物及其制备方法
CN108186554B (zh) * 2016-12-08 2022-12-09 海思科制药(眉山)有限公司 一种地奈德乳膏药用组合物及其制备方法
WO2018133010A1 (fr) * 2017-01-19 2018-07-26 广东东阳光药业有限公司 Préparation pour absorption transdermique et son procédé de préparation
CN107261109A (zh) * 2017-07-18 2017-10-20 华若延 一种用于治疗尿布疹的药物组合物及其制备方法
WO2019022249A1 (fr) * 2017-07-28 2019-01-31 国立大学法人九州大学 Composition d'absorption transdermique à libération contrôlée de minoxidil
US10842729B2 (en) 2017-09-13 2020-11-24 Living Proof, Inc. Color protectant compositions
WO2019055440A1 (fr) 2017-09-13 2019-03-21 Living Proof, Inc. Compositions cosmétiques longue durée
WO2019099966A1 (fr) 2017-11-20 2019-05-23 Living Proof, Inc. Propriétés permettant d'obtenir des performances cosmétiques de longue durée
CN107823070A (zh) * 2017-12-14 2018-03-23 柳州市柳科科技有限公司 一种护手霜及其制作方法
AU2019257739B2 (en) 2018-04-27 2025-01-09 Living Proof, Inc. Long lasting cosmetic compositions
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CN110200887A (zh) * 2019-07-01 2019-09-06 安徽大学 一种多效生发凝胶及其制备方法
KR102356831B1 (ko) * 2021-04-15 2022-02-08 주식회사 바이오빌리프 용액 형태의 국소 투여용 약학 조성물 및 이의 제조방법
WO2024263134A1 (fr) * 2023-06-22 2024-12-26 Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Formulation médicamenteuse sûre et efficace utilisée pour le traitement du psoriasis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029735A1 (fr) * 1996-02-19 1997-08-21 Monash University Promoteurs de penetration dermique et systeme d'administration de medicaments comprenant ces promoteurs
WO1999049835A1 (fr) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Composition acidifiee pour le traitement topique d'affections ungeales et cutanees
WO2001022907A1 (fr) * 1999-09-28 2001-04-05 Zars Apport de medicaments de preparations a changement de phase
WO2001043722A2 (fr) * 1999-12-17 2001-06-21 Atrix Laboratories, Inc. Formulations de gels et d'aerosols pharmaceutiques et methodes pour les appliquer sur la peau et les muqueuses
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US20050276842A1 (en) * 2004-06-07 2005-12-15 Zars, Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2504077B2 (ja) * 1987-10-21 1996-06-05 日産化学工業株式会社 抗真菌剤組成物
JP2635338B2 (ja) * 1987-10-22 1997-07-30 帝國製薬株式会社 保護膜形成型製剤
EP1089770A1 (fr) * 1998-06-29 2001-04-11 The Procter & Gamble Company Article jetable avec traitement des dechets
EP1257248B1 (fr) * 2000-02-16 2011-10-05 CPEX Pharmaceuticals, Inc. Composition pharmaceutique
AU2002248308B2 (en) * 2001-01-09 2006-12-07 Israel Dvoretzky Therapeutic film forming composition and treatment system
TW572878B (en) * 2001-05-11 2004-01-21 Fushimi Pharmaceutical Co Ltd Method for production of sugar alcohol
US20040143026A1 (en) * 2002-12-31 2004-07-22 Shah Kishore R. Bioadhesive hydrophilic composition for treatment of mammalian skin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029735A1 (fr) * 1996-02-19 1997-08-21 Monash University Promoteurs de penetration dermique et systeme d'administration de medicaments comprenant ces promoteurs
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
WO1999049835A1 (fr) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Composition acidifiee pour le traitement topique d'affections ungeales et cutanees
WO2001022907A1 (fr) * 1999-09-28 2001-04-05 Zars Apport de medicaments de preparations a changement de phase
WO2001043722A2 (fr) * 1999-12-17 2001-06-21 Atrix Laboratories, Inc. Formulations de gels et d'aerosols pharmaceutiques et methodes pour les appliquer sur la peau et les muqueuses
US20050276842A1 (en) * 2004-06-07 2005-12-15 Zars, Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
WO2005120473A2 (fr) * 2004-06-07 2005-12-22 Zars, Inc. Compositions adhesives formant une pellicule, pour l'administration dermique de medicaments et methodes d'utilisation desdites compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KONDO, S. ET AL: "Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier.", J PHARMACOBIODYN., vol. 10, 1987, pages 587 - 594, XP002611468 *
PANCHAGNULA, R. ET AL: "Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.", FARMACO, vol. 60, no. 11-12, 26 August 2005 (2005-08-26), pages 894 - 899, XP002611467 *

Also Published As

Publication number Publication date
CA2633489A1 (fr) 2007-06-21
JP2009519940A (ja) 2009-05-21
CN101378729B (zh) 2013-09-11
AU2006326388A1 (en) 2007-06-21
CN101378729A (zh) 2009-03-04
AU2006326388B2 (en) 2013-01-24
CA2633489C (fr) 2013-09-24
WO2007070643A3 (fr) 2008-05-08
EP1959929A2 (fr) 2008-08-27
WO2007070643A2 (fr) 2007-06-21

Similar Documents

Publication Publication Date Title
EP1959929A4 (fr) Compositions et procedes pour le traitement de conditions dermatologiques
IL185540A0 (en) Compositions and methods for treating acne
IL257681A (en) Methods and compositions for the treatment of cancer
IL186963A0 (en) Methods and compositions for treating pain
EP1890712A4 (fr) Compositions et methodes de traitement de la douleur
HK1121952A1 (en) Methods and compositions for treating conditions
EP1899480A4 (fr) Compositions et procédés pour le traitement d'états inflammatoires
IL186973A0 (en) Compositions and methods for treatment for neoplasms
HK1125868A1 (en) Compositions and methods for treating bone
EP2076116A4 (fr) Compositions, procédés, et dispositifs destinés à traiter les maladies hépatiques
EP1959931A4 (fr) Compositions et procedes pour le traitement dermique de la douleur
EP1940437A4 (fr) Compositions et procedes pour le traitement de bacteries
HK1179275A1 (en) Compositions and methods for diagnosing and treating cancer
EP1737482A4 (fr) Compositions et methodes de traitement de maladies
ZA200708575B (en) Methods and compositions for treating or preventing cancer
ZA200608932B (en) Method and compositions for epilation
IL176919A0 (en) Methods and compositions for treating cancer
GB0522287D0 (en) Method and compositions
HK1245679A1 (zh) 用於治療皮膚疾病和病症的方法和組合物
EP1855662A4 (fr) Methodes et compositions destinees a traiter le cancer
ZA200608935B (en) Methods and compositions for epilation
GB0718918D0 (en) Compositions and methods for treating skin conditions
HK1129596A1 (en) Methods and compositions for treating disease
EP1904088A4 (fr) Compositions et methodes de traitement du cancer
GB0524927D0 (en) Compositions and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080625

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ZARS PHARMA, INC.

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120718

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/12 20060101AFI20120712BHEP

Ipc: A61K 31/74 20060101ALI20120712BHEP

17Q First examination report despatched

Effective date: 20140404

17Q First examination report despatched

Effective date: 20140409

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160701